Literature DB >> 8519988

Overexpression of the cystic fibrosis transmembrane conductance regulator in NIH 3T3 cells lowers membrane potential and intracellular pH and confers a multidrug resistance phenotype.

L Y Wei1, M J Stutts, M M Hoffman, P D Roepe.   

Abstract

Because of the similarities between the cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance (MDR) proteins, recent observations of decreased plasma membrane electrical potential (delta psi) in cells overexpressing either MDR protein or the CFTR, and the effects of delta psi on passive diffusion of chemotherapeutic drugs, we have analyzed chemotherapeutic drug resistance for NIH 3T3 cells overexpressing different levels of functional CFTR. Three separate clones not previously exposed to chemotherapeutic drugs exhibit resistance to doxorubicin, vincristine, and colchicine that is similar to MDR transfectants not previously exposed to chemotherapeutic drugs. Two other clones expressing lower levels of CFTR are less resistant. As shown previously these clones exhibit decreased plasma membrane delta psi similar to MDR transfectants, but four of five exhibit mildly acidified intracellular pH in contrast to MDR transfectants, which are in general alkaline. Thus the MDR protein and CFTR-mediated MDR phenotypes are distinctly different. Selection of two separate CFTR clones on either doxorubicin or vincristine substantially increases the observed MDR and leads to increased CFTR (but not measurable MDR or MRP) mRNA expression. CFTR overexpressors also exhibit a decreased rate of 3H -vinblastine uptake. These data reveal a new and previously unrecognized consequence of CFTR expression, and are consistent with the hypothesis that membrane depolarization is an important determinant of tumor cell MDR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8519988      PMCID: PMC1236317          DOI: 10.1016/S0006-3495(95)79962-3

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  63 in total

1.  Intracellular pH and the control of multidrug resistance.

Authors:  S Simon; D Roy; M Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

2.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies.

Authors:  J L Biedler; H Riehm
Journal:  Cancer Res       Date:  1970-04       Impact factor: 12.701

3.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.

Authors:  G J Zaman; M J Flens; M R van Leusden; M de Haas; H S Mülder; J Lankelma; H M Pinedo; R J Scheper; F Baas; H J Broxterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

4.  Novel Cl(-)-dependent intracellular pH regulation in murine MDR 1 transfectants and potential implications.

Authors:  P D Roepe; J H Weisburg; J G Luz; M M Hoffman; L Y Wei
Journal:  Biochemistry       Date:  1994-09-13       Impact factor: 3.162

5.  Analysis of drug transport kinetics in multidrug-resistant cells using a novel coumarin-vinblastine compound.

Authors:  W G Bornmann; P D Roepe
Journal:  Biochemistry       Date:  1994-10-25       Impact factor: 3.162

6.  Selection for MDR1/P-glycoprotein enhances swelling-activated K+ and Cl- currents in NIH/3T3 cells.

Authors:  D B Luckie; M E Krouse; K L Harper; T C Law; J J Wine
Journal:  Am J Physiol       Date:  1994-08

7.  Indirect mechanism of drug transport by P-glycoprotein.

Authors:  P D Roepe
Journal:  Trends Pharmacol Sci       Date:  1994-12       Impact factor: 14.819

8.  Volume-activated chloride current is not related to P-glycoprotein overexpression.

Authors:  Y Dong; K G Chen; G E Durán; K Kouyama; A C Chao; B I Sikic; S V Gollapudi; S Gupta; P Gardner
Journal:  Cancer Res       Date:  1994-10-01       Impact factor: 12.701

9.  Low external pH and osmotic shock increase the expression of human MDR protein.

Authors:  L Y Wei; P D Roepe
Journal:  Biochemistry       Date:  1994-06-14       Impact factor: 3.162

10.  Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels.

Authors:  S P Hardy; H R Goodfellow; M A Valverde; D R Gill; V Sepúlveda; C F Higgins
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

View more
  9 in total

1.  Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.

Authors:  Anna R Kwilas; Mark A Yednak; Liqun Zhang; Rachael Liesman; Peter L Collins; Raymond J Pickles; Mark E Peeples
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Isolation and culture of airway epithelial cells from chronically infected human lungs.

Authors:  S H Randell; L Walstad; U E Schwab; B R Grubb; J R Yankaskas
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

3.  P-glycoprotein structure and evolutionary homologies.

Authors:  I Bosch; J M Croop
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

4.  Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma.

Authors:  Sheng Ding; Bang-Dong Gong; Jian Yu; Jun Gu; Hong-Yu Zhang; Zu-Bin Shang; Qi Fei; Peng Wang; Jing-De Zhu
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

Review 5.  Altered drug translocation mediated by the MDR protein: direct, indirect, or both?

Authors:  P D Roepe; L Y Wei; M M Hoffman; F Fritz
Journal:  J Bioenerg Biomembr       Date:  1996-12       Impact factor: 2.945

Review 6.  The complex relationship between multiple drug resistance and the tumor pH gradient: a review.

Authors:  Tomas Koltai
Journal:  Cancer Drug Resist       Date:  2022-04-03

7.  Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?

Authors:  M M Hoffman; L Y Wei; P D Roepe
Journal:  J Gen Physiol       Date:  1996-10       Impact factor: 4.086

8.  Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.

Authors:  I Sermet-Gaudelus; V Stoven; J P Annereau; V Witko-Sarsat; P Reinert; M Guyot; B Descamps-Latscha; J Y Lallemand; G Lenoir
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

9.  Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.

Authors:  M A Izquierdo; J J Neefjes; A E Mathari; M J Flens; G L Scheffer; R J Scheper
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.